Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1126
DELISTED
Apellis Pharmaceuticals
APLS
| $11.8M | 0.01% |
227,347
+94,198
| +71% | +$5M |
|
1127
CALL
Alcoa
AA
$13.2B
| $11.7M | 0.01% |
258,200
+220,000
| +576% | +$9.58M |
|
1128
WIX.com
WIX
$2.52B
| $11.7M | 0.01% |
152,746
-8,011
| -5% | -$647K |
|
1129
PUT
Cummins
CMI
$88.7B
| $11.7M | 0.01% |
+48,400
| New | +$11.5M |
|
1130
Kanzhun
BZ
$7.36B
| $11.7M | 0.01% |
574,209
-70,471
| -11% | -$1.16M |
|
|
SEE
1131
DELISTED
Sealed Air
SEE
| $11.7M | 0.01% |
234,463
+29,432
| +14% | +$1.44M |
|
|
CMA
1132
DELISTED
Comerica
CMA
| $11.7M | 0.01% |
174,672
-20,135
| -10% | -$1.39M |
|
1133
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $11.7M | 0.01% |
+300,000
| New | +$11.5M |
|
|
1134
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $11.7M | 0.01% |
+300,000
| New | +$11.5M |
|
1135
CALL
Cencora
COR
$61.2B
| $11.6M | 0.01% |
+70,200
| New | +$11.1M |
|
1136
Jazz Pharmaceuticals
JAZZ
$16.7B
| $11.6M | 0.01% |
72,949
+29,462
| +68% | +$4.32M |
|
1137
Bentley Systems
BSY
$10.6B
| $11.5M | 0.01% |
312,415
+43,331
| +16% | +$1.57M |
|
1138
BioNTech
BNTX
$23.5B
| $11.5M | 0.01% |
76,292
+10,898
| +17% | +$1.68M |
|
1139
CALL
Home Depot
HD
$355B
| $11.4M | 0.01% |
+36,200
| New | +$11M |
|
1140
Outset Medical
OM
$90.8M
| $11.4M | 0.01% |
29,478
+29,342
| +21,575% | +$8.27M |
|
1141
Texas Pacific Land
TPL
$23.5B
| $11.4M | 0.01% |
43,704
+5,031
| +13% | +$1.33M |
|
|
GTM
1142
ZoomInfo Technologies
GTM
$1.22B
| $11.4M | 0.01% |
378,062
+25,091
| +7% | +$866K |
|
1143
QuantumScape Corp
QS
$3.74B
| $11.3M | 0.01% |
1,996,512
+1,606,948
| +412% | +$11.9M |
|
1144
CALL
Vertex Pharmaceuticals
VRTX
$126B
| $11.3M | 0.01% |
39,200
+18,000
| +85% | +$5.49M |
|
1145
Immunocore
IMCR
$1.73B
| $11.3M | 0.01% |
197,128
+196,456
| +29,235% | +$11.1M |
|
1146
Floor & Decor
FND
$6.68B
| $11.2M | 0.01% |
161,202
-89,539
| -36% | -$6.51M |
|
1147
Hubbell
HUBB
$27.2B
| $11.1M | 0.01% |
47,483
+35,574
| +299% | +$8.53M |
|
1148
Zions Bancorporation
ZION
$10.3B
| $11.1M | 0.01% |
226,454
+22,947
| +11% | +$1.15M |
|
1149
Aramark
ARMK
$14.7B
| $11.1M | 0.01% |
372,850
+66,984
| +22% | +$1.85M |
|
1150
Brixmor Property Group
BRX
$9.32B
| $11.1M | 0.01% |
490,641
-99,003
| -17% | -$2.12M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.